ACAD 8-K 2026-09-24

ACADIA PHARMACEUTICALS INC (ACAD) 8-K dated 2026-09-24 — accession 0001193125-26-401157. This URL is the filing, not the ACAD hub.

ACADIA PHARMACEUTICALS INC (ACAD) is a biotechnology company listed on US.

ACADIA PHARMACEUTICALS INC filed a 8-K on 2026-09-24. Accession 0001193125-26-401157.

Cached items: 7.01, 8.01, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported ACAD revenue for 2025-12-31 was $1.07B. Net income was $391.0M. Revenue was up 11.9% from 2024-12-31 to 2025-12-31. ACAD currently screens at market cap $3.51B and trailing P/E 15.3.

Not investment advice. The ACAD SEC hub lists recent forms. The stock page is the research view.